1-5 of 5
Toyomasa Katagiri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Expression of Novel Molecules, MICAL2-PV (MICAL2 Prostate Cancer Variants), Increases with High Gleason Score and Prostate Cancer Progression

Free
Shingo Ashida, Mutsuo Furihata, Toyomasa Katagiri, Kenji Tamura, Yoshio Anazawa, Hiroki Yoshioka, Tsuneharu Miki, Tomoaki Fujioka, Taro Shuin, Yusuke Nakamura, Hidewaki Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (9): 2767–2773.
https://doi.org/10.1158/1078-0432.CCR-05-1995
Published: 04 May 2006
View article titled, Expression of Novel Molecules, MICAL2-PV (MICAL2 Prostate Cancer Variants), Increases with High Gleason Score and Prostate Cancer Progression
Open the PDF for Expression of Novel Molecules, MICAL2-PV (MICAL2 Prostate Cancer Variants), Increases with High Gleason Score and Prostate Cancer Progression in another window
Journal Articles

Predicting Response to Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy for Bladder Cancers through Genome-Wide Gene Expression Profiling

Free
Ryo Takata, Toyomasa Katagiri, Mitsugu Kanehira, Tatsuhiko Tsunoda, Taro Shuin, Tsuneharu Miki, Mikio Namiki, Kenjiro Kohri, Yasushi Matsushita, Tomoaki Fujioka, Yusuke Nakamura
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (7): 2625–2636.
https://doi.org/10.1158/1078-0432.CCR-04-1988
Published: 06 April 2005
View article titled, Predicting Response to Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy for Bladder Cancers through Genome-Wide Gene Expression Profiling
Open the PDF for Predicting Response to Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy for Bladder Cancers through Genome-Wide Gene Expression Profiling in another window
Journal Articles

Disruption of Fibroblast Growth Factor Signal Pathway Inhibits the Growth of Synovial Sarcomas: Potential Application of Signal Inhibitors to Molecular Target Therapy

Free
Tatsuya Ishibe, Tomitaka Nakayama, Takeshi Okamoto, Tomoki Aoyama, Koichi Nishijo, Kotaro Roberts Shibata, Yasuko Shima, Satoshi Nagayama, Toyomasa Katagiri, Yusuke Nakamura, Takashi Nakamura, Junya Toguchida
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (7): 2702–2712.
https://doi.org/10.1158/1078-0432.CCR-04-2057
Published: 06 April 2005
View article titled, Disruption of Fibroblast Growth Factor Signal Pathway Inhibits the Growth of Synovial Sarcomas: Potential Application of Signal Inhibitors to Molecular Target Therapy
Open the PDF for Disruption of Fibroblast Growth Factor Signal Pathway Inhibits the Growth of Synovial Sarcomas: Potential Application of Signal Inhibitors to Molecular Target Therapy in another window
Journal Articles

Mouse Homologue of a Novel Human Oncofetal Antigen, Glypican-3, Evokes T-Cell–Mediated Tumor Rejection without Autoimmune Reactions in Mice

Free
Tetsuya Nakatsura, Hiroyuki Komori, Tatsuko Kubo, Yoshihiro Yoshitake, Satoru Senju, Toyomasa Katagiri, Yoichi Furukawa, Michio Ogawa, Yusuke Nakamura, Yasuharu Nishimura
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8630–8640.
https://doi.org/10.1158/1078-0432.CCR-04-1177
Published: 28 December 2004
View article titled, Mouse Homologue of a Novel Human Oncofetal Antigen, Glypican-3, Evokes T-Cell–Mediated Tumor Rejection without Autoimmune Reactions in Mice
Open the PDF for Mouse Homologue of a Novel Human Oncofetal Antigen, Glypican-3, Evokes T-Cell–Mediated Tumor Rejection without Autoimmune Reactions in Mice in another window
Journal Articles

Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis

Free
Yoshihiro Yoshitake, Tetsuya Nakatsura, Mikio Monji, Satoru Senju, Hidetake Matsuyoshi, Hirotake Tsukamoto, Seiji Hosaka, Hiroyuki Komori, Daiki Fukuma, Yoshiaki Ikuta, Toyomasa Katagiri, Yoichi Furukawa, Hiromi Ito, Masanori Shinohara, Yusuke Nakamura, Yasuharu Nishimura
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6437–6448.
https://doi.org/10.1158/1078-0432.CCR-04-0841
Published: 08 October 2004
View article titled, Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis
Open the PDF for Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis in another window